LI, Y., XIE, J., HAN, Y., WANG, H., ZHU, T., WANG, N., . . . LI, T. (2016). Lamivudine monotherapy-based cART is efficacious for HBV treatment in HIV/HBV co-infection when baseline HBV DNA<20,000IU/ml. J Acquir Immune Defic Syndr.
Chicago Style CitationLI, Yijia, et al. "Lamivudine Monotherapy-based CART Is Efficacious for HBV Treatment in HIV/HBV Co-infection When Baseline HBV DNA<20,000IU/ml." J Acquir Immune Defic Syndr 2016.
MLA CitationLI, Yijia, et al. "Lamivudine Monotherapy-based CART Is Efficacious for HBV Treatment in HIV/HBV Co-infection When Baseline HBV DNA<20,000IU/ml." J Acquir Immune Defic Syndr 2016.
Warning: These citations may not always be 100% accurate.